US Patent 7381799 Compositions and methods for inhibiting angiogenesis
Patent 7381799 was granted and assigned to ERGON PHARMACEUTICALS, LLC on June, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Inventor Names
Adonia E. Papathanassiu0
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+352 characters)
Article
Patent abstract
The present invention provides a treatment for mammalian diseases characterized by pathological angiogenesis. The treatment consists of administering therapeutically active dosages of peptides containing specific amino acid sequences or antibodies that bind to cell membrane antigens on the surface of rapidly dividing endothelial cells.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07381799 Compositions and methods for inhibiting angiogenesis US Patent 7381799 Compositions and methods for inhibiting angiogenesis
Infobox
Patent Number
073817990
Patent Number
73817990
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073817990
Date of Patent
June 3, 2008
0Patent Application Number
108064190
Date Filed
March 23, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07381799 Compositions and methods for inhibiting angiogenesis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07381799
Date of patent
June 3, 2008
Patent application number
10806419
Date Filed
March 23, 2004
Patent primary examiner
Find more entities like US Patent 7381799 Compositions and methods for inhibiting angiogenesis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
